SNPS

Synopsys
D

SNPS

Arincen72/100B

Synopsys financials

Yes. Synopsys earned 1.08B USD of net income over the last twelve months, 11.4% of its revenue. It made a profit in 34 of its 36 fiscal years since 1990. Its last loss was in fiscal year 2005.

Revenue (TTM)
9.42B USD
Net income (TTM)
1.08B USD
Free cash flow (TTM)
2.79B USD
Cash and short-term investments
3.61B USD
Total debt
10.84B USD
Shareholders' equity
31.15B USD

Cash, debt and equity as of 31 Jul 2026.

Synopsys earnings

Next earnings · Q4 FY2026
EPS estimate
4.12 USD
Revenue estimate
2.56B USD
Last quarter · Q3 FY2026
EPS3.91Beat +6.5%Revenue2.48BBeat +1.6%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20274.78——+22.16%2.81B——+13.26%
Q2 FY20274.25——+26.90%2.62B——+15.02%
Q1 FY20274.47——+18.62%2.68B——+11.38%
Q4 FY20264.12——+42.07%2.56B——+13.48%
Q3 FY20263.673.91+6.54%+15.34%2.44B2.48B+1.61%+42.37%
Q2 FY20263.153.35+6.35%-8.72%2.25B2.28B+1.12%+41.98%
Q1 FY20263.563.77+5.90%+24.42%2.39B2.41B+0.79%+65.52%
Q4 FY20252.782.90+4.32%-14.71%2.25B2.25B+0.33%+37.83%
Q3 FY20253.803.39-10.79%-1.17%1.77B1.74B-1.62%+14.03%
Q2 FY20253.393.67+8.26%+22.33%1.60B1.60B+0.18%+10.12%

Synopsys growth and profitability

Full income statement
Revenue (TTM)
9.42B USD
Net income (TTM)
1.08B USD
Gross margin
72.38%
Operating margin
9.75%
Net margin
11.43%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY20257.05B+15.12%1.33B-41.14%76.98%12.97%18.89%2.50B+35.46%
FY20246.13B+15.22%2.26B+84.03%79.68%22.13%36.94%1.85B+18.68%
FY20235.32B+15.22%1.23B+24.91%80.62%23.94%23.13%1.56B+16.63%
FY20224.62B+9.79%984.59M+29.98%80.54%24.89%21.33%1.33B+31.70%
FY20214.20B+14.08%757.52M+14.02%79.50%17.48%18.02%1.01B+18.67%

How Synopsys makes its money

License and Maintenance3.49B 49.5%
License2.01B 28.5%
Technology Service1.55B 22.0%
Revenue7.05B 100.0%
Cost of revenue1.62B 23.0%
Gross profit5.43B 77.0%
Research and development2.48B 35.1%
Selling and administration1.84B 26.1%
Other operating expenses192.53M 2.7%
Operating income914.93M 13.0%
Tax55.99M 0.8%
Net income1.33B 18.9%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Synopsys revenue breakdown

By product

FY2025
License and Maintenance: 49.5%License: 28.5%Technology Service: 22.0%49.5%License and Maintenance28.5%License22.0%Technology Service
SegmentRevenueShare of revenueChange on the year
License and Maintenance3.49B49.5%+8.2%
License2.01B28.5%+11.6%
Technology Service1.55B22.0%+41.2%

By region

FY2025
United States: 43.9%Other Countries: 18.5%South Korea: 13.4%Europe: 12.6%China: 11.5%43.9%United States18.5%Other Countries13.4%South Korea12.6%Europe11.5%China
RegionRevenueShare of revenueChange on the year
United States3.10B43.9%+13.2%
Other Countries1.30B18.5%+29.1%
South Korea947.00M13.4%+22.5%
Europe888.52M12.6%+44.6%
China814.32M11.5%-17.7%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY20251.52B1.35B
FY20241.41B1.28B
FY20231.70B1.51B
FY20221.74B1.60B
FY20211.49B1.40B
FY2020991.31M832.55M
FY2019800.51M598.13M
FY2018424.23M322.31M
FY2017634.57M561.01M
FY2016586.64M515.60M

Synopsys financial health

Full balance sheet
Cash and short-term investments
3.61B USD
Total debt
10.84B USD
Net cash
-7.23B USD
Free cash flow (TTM)
2.79B USD
Current ratio
1.34
Debt to equity
0.35
Piotroski score
5 / 9
Altman Z-score
3.75

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20252.96B14.29B1.35B
FY20244.05B684.46M1.28B
FY20231.59B677.60M1.51B
FY20221.57B656.37M1.60B
FY20211.58B666.77M1.40B

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY202548.22B19.90B28.33B
FY202413.07B4.05B8.99B
FY202310.33B4.15B6.15B
FY20229.42B3.86B5.52B
FY20218.75B3.45B5.30B
FY20208.03B3.12B4.91B
FY20196.41B2.32B4.08B
FY20186.15B2.66B3.48B
FY20175.40B2.12B3.28B
FY20165.24B2.05B3.20B

Synopsys valuation

Price to earnings ratio (TTM)
78.19
Forward P/E (FY2027)
23.92
Price to sales (TTM)
9.17
Price to book
2.77
EV / EBITDA (TTM)
25.05

Capital structure

Market capitalization
86.31B USD
+
Total debt
10.84B USD
−
Cash and short-term investments
3.61B USD
=
Enterprise value
93.54B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)19.36————
FY2027 (est.)23.9219.36———
FY2026 (est.)29.7123.92———
Now (TTM)78.1923.789.172.7725.05
FY202555.8236.7310.302.5733.63
FY202434.7540.0512.848.7540.87
FY202358.1039.9413.4311.6245.44
FY202245.4339.949.708.1232.99
FY202166.5037.6711.989.5148.98

Synopsys against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Cloudflare, Fortinet, Block, Zscaler, CrowdStrike Holdings, and Twilio, the US Software - Infrastructure companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median78.2
    32.9118.6
  • Gross marginLowest in 5 years77.0%
    77.0%80.6%
    Against its peers: 2 of 7Peers' median 74.6%
  • Operating marginLowest in 5 years13.0%
    13.0%24.9%
    Against its peers: 2 of 7Peers' median -0.3%
  • Net marginBelow its median18.9%
    18.0%36.9%
    Against its peers: 2 of 7Peers' median -0.6%
  • Return on equityLowest in 5 years4.7%
    4.7%25.2%
    Against its peers: 3 of 7Peers' median -1.0%
  • Free cash flow marginLowest in 5 years19.1%
    19.1%34.7%
    Against its peers: 4 of 7Peers' median 22.0%
  • Revenue growthAt its median15.1%
    9.8%15.2%
    Against its peers: 4 of 7Peers' median 17.9%
  • EPS growthLowest in 5 years-44.6%
    -44.6%83.2%
    Against its peers: 2 of 3Peers' median -23.2%
  • Debt to EBITDAHighest in 5 years5.72×
    0.37×5.72×
    Against its peers: 5 of 7Peers' median 4.30×
  • Current ratioAbove its median1.62
    1.092.44
    Against its peers: 6 of 7Peers' median 1.87

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Synopsys ownership

Institutions
93.09%
Institutional holders
1,524 (+47)
Free float
99.42%

Who owns the shares

Institutions 93.1% Others 6.9%
As of 30 Jun 2026

Shares free to trade

Free float 190.52M shares ·99.4% Closely held 1.11M shares ·0.6%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 20260526.77K54.69K
Q3 20260493.06K183.82K
Q2 20260232.14K51.17K
Q1 2026029.57K12.05K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025160.17M161.68M+3.68%
FY2024153.14M155.94M+0.48%
FY2023152.15M155.20M-0.82%
FY2022153.00M156.49M-0.54%
FY2021152.70M157.34M+1.05%

Common questions about Synopsys's financials

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.